TR201900213T4 - Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu. - Google Patents

Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu. Download PDF

Info

Publication number
TR201900213T4
TR201900213T4 TR2019/00213T TR201900213T TR201900213T4 TR 201900213 T4 TR201900213 T4 TR 201900213T4 TR 2019/00213 T TR2019/00213 T TR 2019/00213T TR 201900213 T TR201900213 T TR 201900213T TR 201900213 T4 TR201900213 T4 TR 201900213T4
Authority
TR
Turkey
Prior art keywords
cell culture
production
continuous cell
polypeptide
related virus
Prior art date
Application number
TR2019/00213T
Other languages
English (en)
Turkish (tr)
Inventor
Grillberger Leopold
Reiter Manfred
Fleischanderl Daniel
Original Assignee
Baxalta GmbH
Baxalta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta GmbH, Baxalta Inc filed Critical Baxalta GmbH
Publication of TR201900213T4 publication Critical patent/TR201900213T4/tr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus
    • C12M3/006Cell injection or fusion devices
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0056Xeno-free medium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/98Xeno-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/00051Methods of production or purification of viral material
    • C12N2710/00052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24087ADAMTS13 endopeptidase (3.4.24.87)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
TR2019/00213T 2009-07-31 2010-08-02 Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu. TR201900213T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23031309P 2009-07-31 2009-07-31

Publications (1)

Publication Number Publication Date
TR201900213T4 true TR201900213T4 (tr) 2019-02-21

Family

ID=42668436

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/00213T TR201900213T4 (tr) 2009-07-31 2010-08-02 Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu.

Country Status (22)

Country Link
US (4) US8580554B2 (cg-RX-API-DMAC7.html)
EP (2) EP2459697B1 (cg-RX-API-DMAC7.html)
JP (2) JP5808742B2 (cg-RX-API-DMAC7.html)
KR (2) KR101752789B1 (cg-RX-API-DMAC7.html)
CN (1) CN102549142B (cg-RX-API-DMAC7.html)
AU (1) AU2010277490B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012002137B8 (cg-RX-API-DMAC7.html)
CA (1) CA2769354A1 (cg-RX-API-DMAC7.html)
CO (1) CO6491119A2 (cg-RX-API-DMAC7.html)
DK (1) DK2459697T3 (cg-RX-API-DMAC7.html)
EA (1) EA022219B1 (cg-RX-API-DMAC7.html)
ES (1) ES2705206T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20182165T1 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN00899A (cg-RX-API-DMAC7.html)
MX (2) MX2012001274A (cg-RX-API-DMAC7.html)
NZ (1) NZ597742A (cg-RX-API-DMAC7.html)
PL (1) PL2459697T3 (cg-RX-API-DMAC7.html)
PT (1) PT2459697T (cg-RX-API-DMAC7.html)
SG (1) SG178176A1 (cg-RX-API-DMAC7.html)
SI (1) SI2459697T1 (cg-RX-API-DMAC7.html)
TR (1) TR201900213T4 (cg-RX-API-DMAC7.html)
WO (1) WO2011012725A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201809632XA (en) 2010-07-08 2018-12-28 Baxalta Inc METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE
SI2665806T1 (sl) * 2011-01-17 2021-11-30 F. Hoffmann-La Roche Ag Aparat za separacijo
DK3626737T3 (da) 2011-05-13 2024-02-05 Octapharma Ag Fremgangsmåde til at forøge produktiviteten af eukaryote celler i produktionen af rekombinant fviii
LT2837680T (lt) 2011-07-01 2020-07-10 Amgen Inc. Žinduolių ląstelių kultūra
CN203129697U (zh) 2013-02-05 2013-08-14 客贝利(厦门)休闲用品有限公司 一种帐篷架杆
CA2856455C (en) 2011-11-24 2022-08-23 Genethon Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
US9574167B2 (en) 2013-02-15 2017-02-21 Pharyx, Inc. Methods and apparatus for independent control of product and reactant concentrations
EP2964663A2 (en) 2013-03-08 2016-01-13 Genzyme Corporation Continuous purification of therapeutic proteins
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
DK2976418T3 (da) 2013-03-19 2021-01-11 Cmc Biologics As Fremgangsmåde til fremstilling af et produkt (f.eks. polypeptid) i en kontinuerlig cellekulturfermenteringsproces
CN105473712B (zh) * 2013-08-30 2022-05-27 葛兰素史密丝克莱恩生物有限公司 在细胞培养物中大规模生产病毒
US11390663B2 (en) 2013-10-11 2022-07-19 Regeneron Pharmaceuticals, Inc. Metabolically optimized cell culture
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
AU2015240354A1 (en) 2014-04-01 2016-11-17 Advantech Bioscience Farmaceutica Ltda. Stabilization of Factor VIII without calcium as an excipient
CN106413741A (zh) 2014-04-01 2017-02-15 爱德技术生物科学有限公司 含低糖‑甘氨酸的稳定因子viii制剂
EP3158055B1 (en) * 2014-06-13 2019-09-11 CSL Limited Improved production of recombinant von willebrand factor in a bioreactor
KR102739324B1 (ko) * 2016-01-26 2024-12-09 베링거 인겔하임 인터내셔날 게엠베하 연결된 관류 대 연속-유동식 교반-탱크 반응기 세포 배양 시스템
KR102414290B1 (ko) 2016-04-15 2022-06-29 베링거 인겔하임 인터내셔날 게엠베하 세포 보유 장치 및 방법
CN110023482B (zh) * 2016-12-21 2023-05-02 豪夫迈·罗氏有限公司 真核细胞的生长控制
IL321253A (en) 2018-05-01 2025-08-01 Amgen Inc Antibodies with a modulated glycan profile
WO2019239780A1 (ja) * 2018-06-15 2019-12-19 富士フイルム株式会社 細胞培養方法、細胞培養装置、及び生産物の製造方法
BR112021003420A2 (pt) 2018-08-31 2021-05-18 Genzyme Corporation resina cromatográfica estéril e uso da mesma em processos de manufatura
CN113355297A (zh) * 2021-06-23 2021-09-07 吉林冠界生物技术有限公司 一种灌流式培养全悬浮mdck细胞生产重组禽流感病毒的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019512A (en) 1989-03-17 1991-05-28 Baxter International Inc. Spin filter for removing substantially cell-free culture medium from suspension cell culture system
US5626734A (en) 1995-08-18 1997-05-06 University Technologies International, Inc. Filter for perfusion cultures of animal cells and the like
CA2422214A1 (en) 2000-10-02 2002-04-11 Novo Nordisk A/S Factor vii glycoforms
CA2466881A1 (en) * 2001-11-28 2003-06-05 Sandoz Gmbh Cell culture process
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
AU2006257073B2 (en) 2005-06-17 2011-08-04 Children's Medical Center Corporation ADAMTS13-comprising compositions having thrombolytic activity
DK2522717T3 (da) * 2006-01-04 2014-04-22 Baxter Int Oligopeptid-frie cellekulturmedier
PT2574677T (pt) * 2007-12-27 2017-10-19 Baxalta Inc Processos para cultura de células

Also Published As

Publication number Publication date
EP3480292A1 (en) 2019-05-08
NZ597742A (en) 2014-02-28
EP2459697A1 (en) 2012-06-06
ES2705206T3 (es) 2019-03-22
EA201270213A1 (ru) 2012-06-29
SI2459697T1 (sl) 2019-03-29
CO6491119A2 (es) 2012-07-31
MX2012001274A (es) 2012-06-01
KR101752789B1 (ko) 2017-06-30
PT2459697T (pt) 2019-01-21
JP2013500710A (ja) 2013-01-10
US10745672B2 (en) 2020-08-18
BR112012002137A2 (pt) 2015-09-15
EP2459697B1 (en) 2018-10-17
AU2010277490A1 (en) 2012-02-09
KR20120038531A (ko) 2012-04-23
DK2459697T3 (en) 2019-01-28
WO2011012725A1 (en) 2011-02-03
CN102549142A (zh) 2012-07-04
CA2769354A1 (en) 2011-02-03
BR112012002137B8 (pt) 2020-05-12
EA022219B1 (ru) 2015-11-30
IN2012DN00899A (cg-RX-API-DMAC7.html) 2015-04-03
WO2011012725A8 (en) 2011-05-05
HRP20182165T1 (hr) 2019-03-08
MX353610B (es) 2018-01-18
CN102549142B (zh) 2014-07-16
US9650612B2 (en) 2017-05-16
BR112012002137B1 (pt) 2020-04-14
US10221400B2 (en) 2019-03-05
JP6177260B2 (ja) 2017-08-09
PL2459697T3 (pl) 2019-04-30
US20110086411A1 (en) 2011-04-14
AU2010277490B2 (en) 2014-08-28
US20180051261A1 (en) 2018-02-22
KR20170077286A (ko) 2017-07-05
US20140038264A1 (en) 2014-02-06
KR101885046B1 (ko) 2018-08-02
US8580554B2 (en) 2013-11-12
SG178176A1 (en) 2012-03-29
JP5808742B2 (ja) 2015-11-10
US20190153400A1 (en) 2019-05-23
JP2015062436A (ja) 2015-04-09

Similar Documents

Publication Publication Date Title
TR201900213T4 (tr) Bir sürekli hücre kültüründe bir polipeptit veya ilişkin virüsün üretim metodu.
MX355650B (es) Produccion de proteinas en medios de cultivo de celulas libres de glutamina.
EA201492183A1 (ru) Клетки для получения рекомбинантной идуронат-2-сульфатазы
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
MY181513A (en) Cell culture compositions and methods for polypeptide production
EA201171018A1 (ru) Биореактор для культивирования клеток млекопитающих
IL222452B (en) A process for preparing a recombinant polypeptide by growing mammalian cells in a serum-free and protein-free cell culture medium
WO2008154014A3 (en) A method for culturing mammalian cells to improve recombinant protein production
PA8778001A1 (es) Metodos de produccion de proteinas mediante la utilizacion de compuestos anti-senescencia
EA201391826A1 (ru) Культивирование клеток млекопитающих
MX356756B (es) Células madre pluripotentes en microportadores.
MX376623B (es) Cultivo celular metabolicamente optimizado.
DK1948789T3 (da) Fremgangsmåde til fremstilling af permanente, humane cellelinjer
AR069956A1 (es) Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas
AR083354A1 (es) Polipeptidos variantes cbh i (celobiohidrolasas i) con reducida inhibicion de producto
MX389666B (es) Induccion de celulas pluripotentes.
MX345141B (es) Mejoras de cultivos celulares.
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
BR112014014116A2 (pt) método de floculação
WO2012145759A3 (en) Methods of protein production and compositions thereof
WO2012103496A3 (en) Expression of soluble viral fusion glycoproteins in mammalian cells
EP2189529A4 (en) RECOMBINANT MAMMALIAN CELLS, PROCESS FOR PRODUCING RECOMBINANT MAMMALIAN CELLS, AND METHOD FOR PRODUCING TARGET PROTEIN
EA200900984A1 (ru) Улучшение клеточного роста
SG196723A1 (en) Purification of cell culture derived alpha1 protease inhibitor
WO2011086447A3 (en) Fermentation process for the preparation of recombinant heterologous proteins